Drug rechallenge following drug-induced liver injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug rechallenge following drug-induced liver injury

Published:2017-06-26 Issue:2 Volume:66 Page:646-654
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hunt Christine M.¹²^ORCID,Papay Julie I.³,Stanulovic Vid⁴⁵,Regev Arie⁶

Affiliation:

1. Department of Medicine; Duke University Medical Center; Durham NC

2. Durham Veterans Administration Medical Center; Durham NC

3. Global Patient Safety; UCB BioSciences; Research Triangle Park NC

4. Accelsiors Clinical Research Organization and Consultancy; Budapest Hungary

5. Semmelweis University School of Pharmacy; Budapest Hungary

6. Global Patient Safety; Eli Lilly and Company; Indianapolis IN

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29152/fullpdf

Reference60 articles.

1. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States;Ostapowicz;Ann Intern Med,2002

2. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system;Goldberg;Gastroenterology,2015

3. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study;Chalasani;Gastroenterology,2015

4. Drug-induced liver injury associated with stevens-Johnson syndrome/toxic epidermal necrolysis: patient characteristics, causes, and outcome in 36 cases;Devarbhavi;Hepatology,2015

5. Case definition and phenotype standardization in drug-induced liver injury;Aithal;Clin Pharmacol Ther,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for causality assessment of idiosyncratic drug‐induced liver injury;Liver International;2024-08-21

2. Effets indésirables de l’association tezacaftor/ivacaftor/elexacaftor pouvant mener à un arrêt de traitement : à propos d’une série de 10 cas;Therapies;2024-07

3. Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions;Pharmacological Research;2024-05

4. Impacto de COVID-19 en enfermedad hepatica pre-existente;Cirugía y Cirujanos;2024-03-12

5. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update;Hepatology International;2024-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3